• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Fingolimod Teva
    / Teva

    Active Ingredient
    Fingolimod 0.5 mg

    Status in Israel

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft


    28 X 0.5 mg

    partial basket chart 62334

    Related information


    One capsule per day (0.5 mg fingolimod).


    For the treatment of patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.


    Known hypersensitivity to active substance or to any of the excipients. Patients who have suffered from myocardial infarction in past 6 months  prior initiation of therapy, unstable angina, stroke or transient ischemic attack, decompensated heart failure that required hospitalization or class III or IV heart failure. Patients with high-degree atrioventricular (AV) block or sick sinus syndrome, unless they have functioning pacemaker. Patients with a baseline QTc interval ≥ 500 ms. Concomitant use with Class Ia or Class III anti-arrhythmic medicines.